Primary hyperaldosteronism Risk Factors: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Primary hyperaldosteronism}} {{CMG}};{{AE}}{{HK}} ==Overview== ==Risk Factors== ==References== {{reflist|2}} {{WH}} {{WS}}" |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{HK}} | {{CMG}};{{AE}}{{HK}} | ||
==Overview== | ==Overview== | ||
The only risk factors in the development of primary hyperaldosteronism are age of [[hypertension]] onset and serum [[potassium]] level. | |||
==Risk Factors== | ==Risk Factors== | ||
* The only risk factors in the development of primary hyperaldosteronism are age of [[hypertension]] onset and serum [[potassium]] level.<ref name="pmid24006040">{{cite journal |vauthors=Sang X, Jiang Y, Wang W, Yan L, Zhao J, Peng Y, Gu W, Chen G, Liu W, Ning G |title=Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China |journal=J. Hypertens. |volume=31 |issue=7 |pages=1465–71; discussion 1471–2 |year=2013 |pmid=24006040 |doi=10.1097/HJH.0b013e328360ddf6 |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 19:45, 17 October 2017
|
Primary hyperaldosteronism Microchapters |
|
Differentiating Primary Hyperaldosteronism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary hyperaldosteronism Risk Factors On the Web |
|
American Roentgen Ray Society Images of Primary hyperaldosteronism Risk Factors |
|
Risk calculators and risk factors for Primary hyperaldosteronism Risk Factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
The only risk factors in the development of primary hyperaldosteronism are age of hypertension onset and serum potassium level.
Risk Factors
- The only risk factors in the development of primary hyperaldosteronism are age of hypertension onset and serum potassium level.[1]
References
- ↑ Sang X, Jiang Y, Wang W, Yan L, Zhao J, Peng Y, Gu W, Chen G, Liu W, Ning G (2013). "Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China". J. Hypertens. 31 (7): 1465–71, discussion 1471–2. doi:10.1097/HJH.0b013e328360ddf6. PMID 24006040.